Poloxamer Market Report, By Grade (Poloxamer 68, Poloxamer 88, Poloxamer 98, Poloxamer 108, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407); Usage (Detergent, Surfactant, Stabilizer, Dispersing Agents, Vivo Absorbance Enhancing); Method (Direct Solubilization, Thin Film methods, Temperature-induced emulsification); and Regions 2024-2032

Market Overview:

"As per Reports and Insights analysis, the global poloxamer market was valued at US$ 6.1 Billion in 2023, and is expected to register a CAGR of 5.9% over the forecast period and reach US$ 10.4 Bn in 2032."

Report Attributes	Details
Base Year	2023
Forecast Years	2024-2032
Historical Years	2021-2023
Market Growth Rate (2024-2032)	5.9%

Poloxamer are a class of synthetic amphiphilic triblock copolymers with the base molecular structure polyoxyethylene–polyoxypropylene–polyoxyethylene (PEO–PPO–PEO), and is produced through polymerization of ethylene oxide and propylene oxide and a multifunctional initiator. Poloxamer oloxamers are freely soluble in water and in alcohol, and some types include P188 (F-68 grade), P237 (F-87 grade), P338 (F-108 grade), and P407 (F-127 grade), with poloxamer 188 (P188) being approved by the Food and Drug Administration (FDA).  These find extensive applications in pharmaceuticals, cosmetics, and food industries for emulsifying, solubilizing, stabilizing, and as antifoaming agents, wetting agents, dispersants, thickeners, and emulsifiers. It is  also used to prevent aggregation and microbial contamination, as well as in food packaging applications. In addition, poloxamers are used in bioengineering, as drug delivery excipients, in gene therapy, injectable scaffolds for loading cells in tissue engineering, and for circumventing the Blood Brain Barrier (BBM) to improve drug delivery to the brain. Poloxamer is also a component in cell culture medium that is widely used in industrial protein production.

The thermoresponsive behavior of the material - transitions from liquid at low temperature and gel at high temperature and process is reversible - allows its use in controlled drug release systems and in tissue engineering applications, among others. Advancements in nonionic poloxamer research enable modifications to tailor properties of poloxamers for specific applications, and some advantages include biocompatibility, low toxicity, and non-ionic nature, making this material suitable for a variety of medical applications. Improving the solubility of poorly water-soluble drugs and enhancing the stability of formulations are other beneficial properties of poloxamer in various end-uses. Increasing demand for pharmaceuticals, cosmetics and personal care products, and packaged food products is a key factor expected to continue to drive revenue growth of the market. 

Poloxamer Market Trends and Drivers:

Demand for controlled drug delivery systems and parenteral formulations has been rising and use of poloxamer has been increasing in the pharmaceutical industry along with rapid expansion and innovations in various fields of medicine. The biocompatibility and low toxicity of poloxamer and increasing use in expanding applications in pharmaceuticals is expected to continue to support market growth. Focus has also been rising in the cosmetics industry on developing stable and effective formulations leading to a surge in the use of poloxamer in creams, lotions, and other personal care products.

Food demand is also increasing substantially, and this is driving demand for poloxamer, which is widely used for texture enhancement, stability, and to extend shelf life of products. The steady shift towards sustainable and bio-based alternatives is also driving demand for biodegradable poloxamers and encouraging the exploration of eco-friendly polymers for various end-uses in this sector. In addition, advancements in poloxamer manufacturing technologies and processes are resulting is easier accessibility and cost-effectiveness of poloxamer and is contributing to a steady growth of the market.

Poloxamer Market Restraining Factors:

Poloxamer may be versatile in a range of applications, but some factors can have a negative impact on demand, supply, and production, and this is having a negative impact on growth of the market. For instance, restrain wider use of poloxamer, particularly in the pharmaceutical and food industries where compliance is crucial. The non-biodegradability nature of poloxamer give rise to environmental concerns is a key factor also hampering adoption to some extent.

Another factor restricting wider use are limitations of poloxamer in terms of thermal stability and susceptibility to degradation under certain conditions. This can restrict its use in formulations that require prolonged shelf life or can be exposed to high temperatures. In addition, high cost factor, especially when compared to alternative materials such as polymeric Micelles, poloxamines, biopolymeric nanohydrogels, and Xanthan gum and other surfactants and emulsifiers are having a negative impact on potential sales of poloxamer in some countries and regions.

Poloxamer Market Player Opportunities:

Companies can leverage emerging opportunities arising from rising demand for more efficient drug delivery systems and by exploring and developing innovative formulations to cater to new requirements driven by the steady trend towards personalized medicine. Also, continuous exploration of novel excipients in the pharmaceutical industry to enhance drug solubility and bioavailability opens up further opportunities for companies to consider. Rising focus on sustainability also presents avenues wherein companies can leverage potential opportunity in segments in the market and market bio-based or eco-friendly variants of poloxamer.

Entering into strategic partnerships and collaborations, and joint Research and Development (R&D) initiatives with pharmaceutical companies, research centers, public and private sectors, and others can present potential to develop and expand product portfolio and expand market reach. can offer opportunities for companies to expand their product portfolios and geographical presence. This approach can also enable formulation of tailored solutions and encourage further innovation in the long-term. Exploring new end-uses and applications and industries, including agriculture and textile can enable entry into untapped markets.

Poloxamer Market Segmentation:

By Grade

• Poloxamer 68
• Poloxamer 88
• Poloxamer 98
• Poloxamer 108
• Poloxamer 124
• Poloxamer 188
• Poloxamer 237
• Poloxamer 338
• Poloxamer 407

Among the grade segments, the Poloxamer 407 segment is expected to account for largest revenue share over the forecast period. This expectation is based on the extensive utilization of Poloxamer 407 across various industries, including pharmaceuticals, cosmetics, and personal care. Its higher molecular weight provides unique properties, making it a preferred choice for applications requiring increased viscosity, stability, and emulsifying capabilities. The versatility and effectiveness of Poloxamer 407 in diverse formulations contributes significantly to wide use and this supports the projected revenue growth for this segment.

By Usage

• Detergent
• Surfactant
• Stabilizer
• Dispersing Agents
• Vivo Absorbance Enhancing

Among the usage segments, the surfactant segment is expected to maintain dominance in terms of revenue share. This projection is supported by the critical role surfactants play in various industries, including pharmaceuticals, cosmetics, and personal care. Poloxamers' surfactant properties, such as ability to reduce surface tension and enhance emulsification, make it  essential in formulations ranging from drug delivery systems to cosmetic products. The widespread demand for effective surfactants in diverse applications contributes significantly to the anticipated revenue growth and adoption of poloxamers.

By Method

• Direct Solubilization
• Thin Film methods
• Temperature-induced emulsification

Among the method segments, the direct solubilization segment is expected to account for largest revenue share. This projection is based on the simplicity and efficiency of direct solubilization, allowing for easy incorporation of poloxamers into various formulations. The method's versatility caters to pharmaceuticals, cosmetics, and personal care industries, where straightforward integration is crucial, and direct solubilization method also aligns with the demand for efficient and convenient processes.

By End-Use

• Biomedical Pharmaceutical
• Cosmetics
• Personal Care Products
• Others

The biomedical and pharmaceutical segment is expected to account for largest revenue share among the end-use segments in the poloxamer market. This expectation is driven by the increasing demand for advanced drug delivery systems and formulations that require the unique properties of poloxamers. Their role in enhancing solubility, stability, and controlled release of drugs aligns with the pharmaceutical industry's continuous pursuit of innovative solutions. As pharmaceutical research and development expands, the demand for poloxamers in this sector is expected to grow, driving substantial revenue and adoption within the biomedical and pharmaceutical segment.

By Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Poland
• Benelux
• Nordic
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• ASEAN
• Australia New Zealand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina

Middle East Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

The global poloxamer market is divided into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America, Asia Pacific, and Europe have been significant contributors to the Poloxamer market. North America, led by the United States, has a robust pharmaceutical industry, contributing to poloxamer demand. In Asia Pacific, countries such as China and India, with expanding pharmaceutical and cosmetic sectors, are key players. Europe, with its well-established pharmaceutical and cosmetic industries, also contributes significantly.

Some common factors driving overall poloxamer market growth include increasing demand in pharmaceuticals for drug delivery systems, expanding  need for stable formulations in the cosmetics industry, and the versatility of Poloxamers in various applications, such as stabilizers and dispersing agents, across industries. 

Leading Companies in Poloxamer Market & Competitive Landscape:

The competitive landscape in the global poloxamer market is characterized by the presence of key players implementing various strategies to maintain their positions and expand their consumer base. Leading companies are increasingly focusing on research and development activities to introduce innovative formulations and address specific industry needs. Strategic collaborations and partnerships with pharmaceutical and cosmetic companies facilitate the development of customized solutions, expanding their product portfolios. Additionally, investments in sustainable and bio-based alternatives align with the growing market trend towards environmentally conscious practices, catering to a broader consumer base. Some companies are also adopting mergers and acquisitions to enhance their market presence and gain a competitive edge. Overall, the competitive landscape reflects a dynamic environment with a focus on innovation, strategic alliances, and sustainability to ensure continued growth and market leadership.

These companies include:

• BASF
• Anshul Life Sciences
• DeWolf Chemicals
• Solvay
• Sirion Biotech Gmbh
• BioPharm International
• Sigma-Aldrich
• Planet Science
• SpecialChem

Recent Developments:

• December 2022: BASF Pharma Solutions secured acceptance from the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of New Drugs, for its branded excipient, Soluplus, into the pilot program for the Review of Innovation and Modernization of Excipients (PRIME). The objective of the program is to reduce the risk and burden for pharmaceutical companies that would explore usage of novel excipients for modern drug development challenges as well as enable excipient manufacturers such as BASF to obtain FDA review of novel excipients prior to use in an FDA-approved drug. Soluplus, according to studies, exhibits physicochemical attributes to improve solubilization, maintain supersaturation, prevent recrystallization of drugs, improve aqueous solubility and oral bioavailability of poorly soluble drugs, and improve solubilizing properties of many poorly soluble BCS class II drug.
• March 2022: According to a study published in The Federation of American Societies for Experimental Biology Journal in 2022 by researchers at Children’s Hospital of Philadelphia (CHOP), linking a tumor-killing prodrug to a macromolecular carrier of the poloxamer family improves retention of the drug in treatment-resistant neuroblastoma tumors. This leads to rapid tumor regression and lasting therapeutic responses in several preclinical models. The polymer-linked prodrug developed is a medication that is inert until converted by the body into a pharmacologically active drug - SN22 – and belongs to a family of camptothecins, compounds known to promote death of rapidly dividing cells, thereby destroying the tumors.

Poloxamer Market Research Scope

Report Metric	Report Details
Market size available for the years	2021-2023
Base Year	2023
Forecast Period	2024-2032
Compound Annual Growth Rate (CAGR)	5.9%
Segment covered	Grade, Usage, Method, End-Use, and Region
Regions Covered	North America: The U.S. Canada Latin America: Brazil, Mexico, Argentina, Rest of Latin America Asia Pacific: China, India, Japan, Australia New Zealand, ASEAN, Rest of Asia Pacific Europe: Germany, The U.K., France, Spain, Italy, Russia, Poland, BENELUX, NORDIC, Rest of Europe The Middle East Africa: Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, and Rest of MEA
Fastest Growing Country in Europe	Germany
Largest Market in Asia Pacific	China
Key Players	BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem